JP2015084803A - 液体投与具 - Google Patents
液体投与具 Download PDFInfo
- Publication number
- JP2015084803A JP2015084803A JP2013223311A JP2013223311A JP2015084803A JP 2015084803 A JP2015084803 A JP 2015084803A JP 2013223311 A JP2013223311 A JP 2013223311A JP 2013223311 A JP2013223311 A JP 2013223311A JP 2015084803 A JP2015084803 A JP 2015084803A
- Authority
- JP
- Japan
- Prior art keywords
- port
- liquid
- filter
- air
- administration device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 125
- 230000001954 sterilising effect Effects 0.000 claims abstract description 67
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 63
- 241000894006 Bacteria Species 0.000 claims abstract description 34
- 210000004556 brain Anatomy 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 21
- 239000005871 repellent Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 230000002940 repellent Effects 0.000 claims description 5
- 230000000903 blocking effect Effects 0.000 abstract 3
- -1 polypropylene Polymers 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000009545 invasion Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 7
- 238000001802 infusion Methods 0.000 description 6
- 208000003174 Brain Neoplasms Diseases 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000000520 microinjection Methods 0.000 description 4
- 230000037452 priming Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 239000004952 Polyamide Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000008076 immune mechanism Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000004627 regenerated cellulose Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- FPVKHBSQESCIEP-UHFFFAOYSA-N (8S)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol Natural products C1C(O)C(CO)OC1N1C(NC=NCC2O)=C2N=C1 FPVKHBSQESCIEP-UHFFFAOYSA-N 0.000 description 1
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 description 1
- 206010001526 Air embolism Diseases 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 1
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
- 239000002147 L01XE04 - Sunitinib Substances 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- AHHFEZNOXOZZQA-ZEBDFXRSSA-N Ranimustine Chemical compound CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O AHHFEZNOXOZZQA-ZEBDFXRSSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229960002170 azathioprine Drugs 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229960005395 cetuximab Drugs 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960001904 epirubicin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 1
- 229960002584 gefitinib Drugs 0.000 description 1
- 208000029824 high grade glioma Diseases 0.000 description 1
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 1
- 229960002411 imatinib Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229960004768 irinotecan Drugs 0.000 description 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000011614 malignant glioma Diseases 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000025090 microtubule depolymerization Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VFEDRRNHLBGPNN-UHFFFAOYSA-N nimustine Chemical compound CC1=NC=C(CNC(=O)N(CCCl)N=O)C(N)=N1 VFEDRRNHLBGPNN-UHFFFAOYSA-N 0.000 description 1
- 229960001420 nimustine Drugs 0.000 description 1
- 229960001756 oxaliplatin Drugs 0.000 description 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960002340 pentostatin Drugs 0.000 description 1
- FPVKHBSQESCIEP-JQCXWYLXSA-N pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960002185 ranimustine Drugs 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229940034107 sulfazine Drugs 0.000 description 1
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 1
- 229960001796 sunitinib Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 229960004964 temozolomide Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 description 1
- 229960000575 trastuzumab Drugs 0.000 description 1
Images
Landscapes
- Details Of Valves (AREA)
- Multiple-Way Valves (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
10 管体(第2の器具)、
20 ハブ部、
31 第1のポート、
32 第2のポート、
323 除菌フィルタ用放射状支持部(除菌フィルタ用支持部)、
33 第3のポート、
333 エアフィルタ用放射状支持部(エアフィルタ用支持部)、
40 エアフィルタ、
60 除菌フィルタ、
73 下流側除菌フィルタ放射状支持部(除菌フィルタ用支持部)、
80 切替部、
100 シリンジ(第1の器具)。
Claims (7)
- 液体を生体へ投与するための液体投与具であって、
液体の供給源となる第1の器具が接続される第1のポートと、
細菌を通さないが液体を通す除菌フィルタが流路に設けられるとともに、液体を生体へ投与するための第2の器具が接続される第2のポートと、
空気を通すエアフィルタが流路に設けられる第3のポートと、
前記第2のポートを遮断して前記第1のポートと第3のポートとを連通させる第1の状態、前記第3のポートを遮断して前記第1のポートと第2のポートとを連通させる第2の状態、および前記第1のポートを遮断して前記第2のポートと第3のポートとを連通させる第3の状態を取り得る切替部と、を有する液体投与具。 - 前記第2の器具は、前記第2のポートに予め離脱不能に接続される管体である請求項1に記載の液体投与具。
- 前記除菌フィルタは、当該除菌フィルタの少なくとも一方のフィルタ面が、当該フィルタ面に沿って線状に延在してフィルタ面と接する除菌フィルタ用支持部により支持される請求項1または2に記載の液体投与具。
- 前記エアフィルタは、当該エアフィルタの少なくとも一方のフィルタ面が、当該フィルタ面に沿って線状に延在してフィルタ面と接するエアフィルタ用支持部により支持される請求項1〜3のいずれか1項に記載の液体投与具。
- 前記エアフィルタは、撥水加工が施されている請求項1〜4のいずれか1項に記載の液体投与具。
- 腫瘍への物質の対流増加送達に用いられる請求項1〜5のいずれか1項に記載の液体投与具。
- 脳への物質の対流増加送達に用いられる請求項1〜6のいずれか1項に記載の液体投与具。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013223311A JP6301104B2 (ja) | 2013-10-28 | 2013-10-28 | 液体投与具 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013223311A JP6301104B2 (ja) | 2013-10-28 | 2013-10-28 | 液体投与具 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015084803A true JP2015084803A (ja) | 2015-05-07 |
JP6301104B2 JP6301104B2 (ja) | 2018-03-28 |
Family
ID=53048297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013223311A Active JP6301104B2 (ja) | 2013-10-28 | 2013-10-28 | 液体投与具 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6301104B2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105276230A (zh) * | 2015-11-30 | 2016-01-27 | 张会珍 | 一种水龙头 |
JP2020527460A (ja) * | 2017-07-20 | 2020-09-10 | ジェムティア メディカル (ジャンス) インコーポレイテッド | 濾過装置およびそれを含む濾過輸液容器 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0588554U (ja) * | 1992-04-30 | 1993-12-03 | 日本ミリポア工業株式会社 | フィルター付輸液用三方活栓 |
JP2003260134A (ja) * | 2002-03-11 | 2003-09-16 | Yukiyasu Okumura | 院内感染防止輸液システム |
US20050004534A1 (en) * | 2001-12-26 | 2005-01-06 | Lockwood Jeffery S | Vented vacuum bandage and method |
JP2009160452A (ja) * | 2009-04-22 | 2009-07-23 | Terumo Corp | 輸液チューブセット |
JP2009297518A (ja) * | 2008-06-12 | 2009-12-24 | Codman & Shurtleff Inc | 拍動流薬物送達 |
WO2010001939A1 (ja) * | 2008-07-02 | 2010-01-07 | テルモ株式会社 | コネクタおよび輸液チューブセット |
JP2012200437A (ja) * | 2011-03-25 | 2012-10-22 | Terumo Corp | 多方活栓および薬液投与具 |
WO2013119823A1 (en) * | 2012-02-07 | 2013-08-15 | Yukon Medical, Llc | Transfer device with fluid filter |
-
2013
- 2013-10-28 JP JP2013223311A patent/JP6301104B2/ja active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0588554U (ja) * | 1992-04-30 | 1993-12-03 | 日本ミリポア工業株式会社 | フィルター付輸液用三方活栓 |
US20050004534A1 (en) * | 2001-12-26 | 2005-01-06 | Lockwood Jeffery S | Vented vacuum bandage and method |
JP2003260134A (ja) * | 2002-03-11 | 2003-09-16 | Yukiyasu Okumura | 院内感染防止輸液システム |
JP2009297518A (ja) * | 2008-06-12 | 2009-12-24 | Codman & Shurtleff Inc | 拍動流薬物送達 |
WO2010001939A1 (ja) * | 2008-07-02 | 2010-01-07 | テルモ株式会社 | コネクタおよび輸液チューブセット |
JP2009160452A (ja) * | 2009-04-22 | 2009-07-23 | Terumo Corp | 輸液チューブセット |
JP2012200437A (ja) * | 2011-03-25 | 2012-10-22 | Terumo Corp | 多方活栓および薬液投与具 |
WO2013119823A1 (en) * | 2012-02-07 | 2013-08-15 | Yukon Medical, Llc | Transfer device with fluid filter |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105276230A (zh) * | 2015-11-30 | 2016-01-27 | 张会珍 | 一种水龙头 |
JP2020527460A (ja) * | 2017-07-20 | 2020-09-10 | ジェムティア メディカル (ジャンス) インコーポレイテッド | 濾過装置およびそれを含む濾過輸液容器 |
JP7048734B2 (ja) | 2017-07-20 | 2022-04-05 | ジェムティア メディカル (ジャンス) インコーポレイテッド | 濾過装置およびそれを含む濾過輸液容器 |
US11344672B2 (en) | 2017-07-20 | 2022-05-31 | Gemtier Medical (Jiangsu) Inc. | Filter device and filtering infusion container comprising same |
Also Published As
Publication number | Publication date |
---|---|
JP6301104B2 (ja) | 2018-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101857491B1 (ko) | 약병들의 연결을 위한 개선된 게이트를 가진 튜빙 세트 | |
JP6462759B2 (ja) | 閉鎖式および通気用の危険有害性薬物のivセットを提供するためのシステムおよび方法 | |
JP5833638B2 (ja) | 閉鎖式および通気用の危険有害性薬物のivセットを提供するためのシステムおよび方法 | |
JP6013357B2 (ja) | 液体を注入するためのインサートおよびバイアル | |
JP6211925B2 (ja) | 閉鎖式および通気用の危険有害性薬物のivセットを提供するためのシステムおよび方法 | |
EP3081247B1 (en) | Tubing set having a gate for the connection of vials | |
JP6076390B2 (ja) | 薬物の注入のためのインサートを有する配管セット | |
US11638811B2 (en) | Percutaneous access apparatus | |
US9498615B2 (en) | Insert for the infusion of drugs | |
JP6301104B2 (ja) | 液体投与具 | |
JP2013085822A (ja) | 薬液セット及び薬液投与方法 | |
JP2015015988A (ja) | 医療用器具 | |
SE525294C2 (sv) | Kateteranordning samt infusionssystem med inre och yttre kateter | |
CN107106763A (zh) | 具有排气特征的流体导管组件 | |
KR20160012729A (ko) | 필터를 포함하는 수액 세트 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161013 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170807 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170922 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180219 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180228 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6301104 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |